Ibrutinib-induced pulmonary angiotensin-converting enzyme activation promotes atrial fibrillation in rats
Summary: The molecular mechanism of ibrutinib-induced atrial fibrillation (AF) remains unclear. We here demonstrate that treating rats with ibrutinib for 4 weeks resulted in the development of inducible AF, left atrial enlargement, atrial fibrosis, and downregulation of connexin expression, which we...
Main Authors: | Sen Yan, Wei Xu, Ning Fang, Luyifei Li, Ning Yang, Xinbo Zhao, Hongting Hao, Yun Zhang, Qian Liang, Zhiqi Wang, Yu Duan, Song Zhang, Yongtai Gong, Yue Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224001470 |
Similar Items
-
n-3 polyunsaturated fatty acids delay intervertebral disc degeneration by inhibiting nuclear receptor coactivator 4-mediated iron overload
by: Xiang Ao, et al.
Published: (2024-02-01) -
Polymorphisms of the angiotensin-converting enzyme and angiotensinogen gene in patients with atrial fibrillation
by: Nurdan Papila Topal, et al.
Published: (2011-12-01) -
Canagliflozin combined with aerobic exercise protects against chronic heart failure in rats
by: Helin Sun, et al.
Published: (2024-03-01) -
Gasdermin D promotes hyperuricemia-induced renal tubular injury through RIG-I/caspase-1 pathway
by: Lisha Ma, et al.
Published: (2023-12-01) -
The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db mice
by: Bing Li, et al.
Published: (2024-03-01)